| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1039870378 |
| P356 | DOI | 10.1186/1475-2875-9-141 |
| P932 | PMC publication ID | 2890676 |
| P698 | PubMed publication ID | 20500856 |
| P5875 | ResearchGate publication ID | 44628791 |
| P50 | author | Samuel Granjeaud | Q41472640 |
| Lionel Almeras | Q56417471 | ||
| Albin Fontaine | Q57298104 | ||
| Bruno Pradines | Q60044507 | ||
| Christophe Rogier | Q60048789 | ||
| Sébastien Briolant | Q60244022 | ||
| Maya Belghazi | Q114388085 | ||
| Thierry Fusai | Q114440111 | ||
| Nathalie Wurtz | Q114721447 | ||
| Elodie Boucomont-Chapeaublanc | Q114721456 | ||
| P2860 | cites work | Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance | Q24548472 |
| Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum | Q24674922 | ||
| iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and disease | Q27300851 | ||
| Malaria: progress, perils, and prospects for eradication | Q27485634 | ||
| Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3. | Q27631119 | ||
| Proteomic analysis identifies novel proteins of the Maurer's clefts, a secretory compartment delivering Plasmodium falciparum proteins to the surface of its host cell | Q27973506 | ||
| Large-scale differential proteome analysis in Plasmodium falciparum under drug treatment | Q28474424 | ||
| Identification of proteins targeted by the thioredoxin superfamily in Plasmodium falciparum | Q28475176 | ||
| Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture | Q29547549 | ||
| Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum | Q30080010 | ||
| Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast | Q30080014 | ||
| New antigenic candidates in multiple sclerosis: identification by serological proteome analysis. | Q31083807 | ||
| Towards a proteomic definition of CoArtem action in Plasmodium falciparum malaria. | Q31160199 | ||
| Proteases and chaperones are the most abundant proteins in the parasitophorous vacuole of Plasmodium falciparum-infected erythrocytes | Q33233622 | ||
| Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. | Q33235253 | ||
| SELDI-TOF-MS analysis of chloroquine resistant and sensitive Plasmodium falciparum strains | Q33273389 | ||
| Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity | Q33381649 | ||
| Nifs and Sufs in malaria | Q34368406 | ||
| Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline | Q34601191 | ||
| Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay | Q35757486 | ||
| The sensitivity of Plasmodium protein synthesis to prokaryotic ribosomal inhibitors | Q36847579 | ||
| Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial | Q36865242 | ||
| Quantitative protein expression profiling reveals extensive post-transcriptional regulation and post-translational modifications in schizont-stage malaria parasites | Q37105948 | ||
| The use of proteomics to study infectious diseases | Q37161058 | ||
| Recommendations for clinical practice. Management and prevention of imported Plasmodium falciparum malaria. (Revision 2007 of the 1999 Consensus conference). Short text | Q37223657 | ||
| In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron | Q39477444 | ||
| Protein and nucleic acid synthesis during synchronized growth of Plasmodium falciparum | Q39969820 | ||
| Inhibition of mitochondrial and plastid activity of Plasmodium falciparum by minocycline | Q41917717 | ||
| Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates. | Q41921907 | ||
| Chloroquine mediates specific proteome oxidative damage across the erythrocytic cycle of resistant Plasmodium falciparum | Q41941122 | ||
| Susceptibility of Plasmodium falciparum isolates to doxycycline is associated with pftetQ sequence polymorphisms and pftetQ and pfmdt copy numbers | Q43237750 | ||
| Mitochondria as the site of action of tetracycline on Plasmodium falciparum | Q43484102 | ||
| Comprehensive analysis of the Brassica juncea root proteome in response to cadmium exposure by complementary proteomic approaches. | Q46062913 | ||
| Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya | Q46738998 | ||
| The effects of anti-bacterials on the malaria parasite Plasmodium falciparum. | Q47823743 | ||
| Indirect inhibition by antibiotics of nucleotide and deoxynucleotide biosynthesis in Plasmodium falciparum | Q47836450 | ||
| Malaria chemoprophylaxis using proguanil/dapsone combinations on the Thai-Cambodian border | Q47861008 | ||
| Phenotypic and transcriptomic analyses of Plasmodium falciparum protein kinase A catalytic subunit inhibition | Q47914645 | ||
| Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry | Q47915916 | ||
| Current role of doxycycline in the chemoprophylaxis of Plasmodium falciparum malaria | Q48023960 | ||
| Depression of Plasmodium falciparum dihydroorotate dehydrogenase activity in in vitro culture by tetracycline | Q69819433 | ||
| Effects of mitochondrial protein synthesis inhibitors on the incorporation of isoleucine into Plasmodium falciparum in vitro | Q70396864 | ||
| Multi-Q: a fully automated tool for multiplexed protein quantitation | Q80196295 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| doxycycline | Q422442 | ||
| P304 | page(s) | 141 | |
| P577 | publication date | 2010-05-25 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | Plasmodium falciparum proteome changes in response to doxycycline treatment | |
| P478 | volume | 9 |
| Q36071499 | Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline |
| Q28082097 | Advances in Development of New Treatment for Leishmaniasis |
| Q34847941 | Altered protein networks and cellular pathways in severe west nile disease in mice. |
| Q38632903 | Antiplasmodial drug targets: a patent review (2000 - 2013). |
| Q47152311 | BdorOBP2 plays an indispensable role in the perception of methyl eugenol by mature males of Bactrocera dorsalis (Hendel). |
| Q48008146 | Cationic detergents enable the separation of membrane proteins of Plasmodium falciparum-infected erythrocytes by 2D gel electrophoresis |
| Q35138507 | Cerebrospinal fluid biomarker candidates associated with human WNV neuroinvasive disease |
| Q37308069 | Comparison of protein expression pattern between the Plasmodium falciparum chloroquine-resistant RKL9 and chloroquine-sensitive MRC2 strains |
| Q35494778 | Effects of cyclin-dependent kinase inhibitor Purvalanol B application on protein expression and developmental progression in intra-erythrocytic Plasmodium falciparum parasites |
| Q51064915 | Evaluation of three-dimensional gel electrophoresis to improve quantitative profiling of complex proteomes. |
| Q38483901 | Hepatocyte pathway alterations in response to in vitro Crimean Congo hemorrhagic fever virus infection |
| Q34438960 | In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine |
| Q34123636 | In vitro antiplasmodial activity of cepharanthine |
| Q44332674 | Isolation of erythrocytes infected with viable early stages of Plasmodium falciparum by flow cytometry |
| Q28540749 | Kinetic analysis of mouse brain proteome alterations following Chikungunya virus infection before and after appearance of clinical symptoms |
| Q28066421 | Muddled mechanisms: recent progress towards antimalarial target identification |
| Q21184008 | Organellar proteomics reveals hundreds of novel nuclear proteins in the malaria parasite Plasmodium falciparum |
| Q27010002 | Parasites, proteomes and systems: has Descartes' clock run out of time? |
| Q33653123 | Plasmodium falciparum malaria: proteomic studies |
| Q92498482 | Proteomic analysis of Plasmodium falciparum response to isocryptolepine derivative |
| Q64988738 | Proteomic analysis revealed alterations of the Plasmodium falciparum metabolism following salicylhydroxamic acid exposure. |
| Q57251411 | Proteomics |
| Q35144125 | Quantitative time-course profiling of parasite and host cell proteins in the human malaria parasite Plasmodium falciparum |
| Q37984669 | Strategies to dissect parasite proteomes |
| Q30041886 | Studies with the Plasmodium falciparum hexokinase reveal that PfHT limits the rate of glucose entry into glycolysis |
| Q37894700 | Target identification and validation of novel antimalarials |
| Q26778176 | Tetracyclines in malaria |
| Q98569561 | The NTP generating activity of pyruvate kinase II is critical for apicoplast maintenance in plasmodium falciparum |
| Q33560396 | The end of a dogma: the safety of doxycycline use in young children for malaria treatment |
| Q57443233 | Transcriptomics and proteomics |
| Q26745676 | Translational regulation in blood stages of the malaria parasite Plasmodium spp.: systems-wide studies pave the way |
| Q36666924 | Understanding the Heat Shock Response in the Sea Cucumber Apostichopus japonicus, Using iTRAQ-Based Proteomics |
Search more.